During this webinar, we will explore the possibilities offered by a phase-specific regulatory strategy for overcoming challenges associated with the CMC (Chemistry, Manufacturing, and Controls) approach for ATMPs.

The discussion will be centered on our comprehensive experiences in handling oncolytic viruses. Specifically, we will focus on the intricacies involved in the production of egg-based vaccines, followed by an illuminating presentation of data related to adeno-associated virus (AAV).

Join us to learn about the latest innovations in ddPCR and how they can help you bring new and safe gene therapies to market faster!

Join us as we explore the Pioneer Antibody Discovery Platform, an innovative solution that revolutionizes the field of biotherapeutics with its state-of-art phage display library.

In this webinar, CPI will discuss its collaborative programs (Grand Challenges) and how they look to address the challenges posed by the innovations in oligonucleotide manufacturing.

In this webinar, Matthew Schiesher from Cambrex delves deeper into this process, enlightening attendees on the optimal ways to guide projects from conception to completion, and how to incorporate design of experiments to set critical process parameters and proven acceptable ranges.